NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

BSX

Boston Scientific Corp

Apr 28 • 04:00PM ET

102.18

Dollar change +0.28
Percentage change 0.27	%

Healthcare • Medical Devices • USA • NYSE

Peers: MDT ABT JNJ SYK ZBH ISRG BDX EW HOLX XRAY

| Held by: VTI VOO SPY IVV VUG XLV IHI VHT IWD IVW

Scroll to Statements

Index	S&P 500	P/E	74.94	EPS (ttm)	1.36	Insider Own	0.47%	Shs Outstand	1.48B	Perf Week	9.19%
Market Cap	151.13B	Forward P/E	31.03	EPS next Y	3.29	Insider Trans	-8.33%	Shs Float	1.47B	Perf Month	1.37%
Income	2.03B	PEG	5.36	EPS next Q	0.73	Inst Own	92.05%	Short Float	0.98%	Perf Quarter	-0.09%
Sales	17.55B	P/S	8.61	EPS this Y	16.07%	Inst Trans	-0.98%	Short Ratio	1.70	Perf Half Y	16.84%
Book/sh	14.76	P/B	6.92	EPS next Y	13.02%	ROA	4.97%	Short Interest	14.49M	Perf Year	40.15%
Cash/sh	0.35	P/C	287.87	EPS next 5Y	13.98%	ROE	9.03%	52W Range	70.97 - 107.17	Perf YTD	14.40%
Dividend Est.	-	P/FCF	57.14	EPS past 5Y	-17.84%	ROI	6.53%	52W High	-4.66%	Beta	0.69
Dividend TTM	-	Quick Ratio	0.64	Sales past 5Y	9.77%	Gross Margin	68.82%	52W Low	43.98%	ATR (14)	3.26
Dividend Ex-Date	-	Current Ratio	1.08	EPS Y/Y TTM	14.31%	Oper. Margin	16.79%	RSI (14)	60.23	Volatility	2.39% 3.79%
Employees	53000	Debt/Eq	0.52	Sales Y/Y TTM	19.35%	Profit Margin	11.58%	Recom	1.41	Target Price	120.21
Option/Short	Yes / Yes	LT Debt/Eq	0.43	EPS Q/Q	34.69%	Payout	0.00%	Rel Volume	0.91	Prev Close	101.90
Sales Surprise	2.00%	EPS Surprise	11.46%	Sales Q/Q	20.93%	Earnings	Apr 23 BMO	Avg Volume	8.50M	Price	102.18
SMA20	6.04%	SMA50	2.87%	SMA200	13.46%	Trades		Volume	7,742,699	Change	0.27%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-16-25	Upgrade	Needham	Hold → Buy	$113
Jan-10-25	Upgrade	Deutsche Bank	Hold → Buy	$108
Oct-18-24	Downgrade	Needham	Buy → Hold
May-30-24	Initiated	Goldman	Buy	$90
Feb-01-24	Upgrade	Mizuho	Neutral → Buy	$65 → $80
Jul-19-23	Initiated	Robert W. Baird	Outperform	$59
Jun-30-23	Initiated	CL King	Buy	$64
May-30-23	Resumed	Morgan Stanley	Overweight	$58
Mar-29-23	Initiated	UBS	Buy	$57
Dec-22-22	Initiated	Mizuho	Neutral	$52
Dec-20-22	Resumed	Citigroup	Buy	$54
Oct-18-22	Initiated	Barclays	Overweight	$49
Oct-12-22	Initiated	Jefferies	Buy	$50
Jul-06-22	Initiated	Wolfe Research	Outperform	$43
May-27-22	Upgrade	Needham	Hold → Buy	$48
Apr-13-22	Resumed	Truist	Buy	$52
Mar-02-22	Resumed	BofA Securities	Buy	$55
Dec-10-21	Initiated	RBC Capital Mkts	Outperform	$51
May-26-21	Downgrade	Needham	Buy → Hold
May-25-21	Initiated	Barclays	Overweight	$51

Show Previous Ratings

Today 02:24PM	These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth (Investor's Business Daily)
01:26PM	EMEA Growth & Product Launches to Support Boston Scientific Stock (Zacks)
09:30AM	Wall Street Analysts Think Boston Scientific (BSX) Is a Good Investment: Is It? (Zacks)
07:34AM	The Zacks Analyst Blog Highlights Walmart, Toyota Motor, Boston Scientific and Autoscope (Zacks)
07:26AM	The Zacks Analyst Blog Highlights Abbott Laboratories, Boston Scientific and Medtronic (Zacks)
02:22PM	Loading…
Apr-27-25 02:22PM	Baron Health Care Fund Q1 2025 Shareholder Letter (Seeking Alpha)
Apr-26-25 08:00AM	MercadoLibre, The Amazon Of Latin America, Leads Five Stocks Near Buy Points (Investor's Business Daily)
Apr-25-25 04:53PM	Top Stock Reports for Walmart, Toyota Motor & Boston Scientific (Zacks)
03:00PM	Tariffs Cast a Shadow on Abbott's 2025 View: Time to Sell ABT Stock? (Zacks)
12:45PM	Here is Why Growth Investors Should Buy Boston Scientific (BSX) Now (Zacks)
12:00PM	Boston Scientific (BSX) Upgraded to Buy: Here's What You Should Know (Zacks)
12:00PM	MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up (Zacks)
09:50AM	Here's Why Boston Scientific (BSX) is a Strong Momentum Stock (Zacks)
09:40AM	Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? (Zacks)
06:52AM	Boston Scientific reports outcomes from Farapulse and Farapoint trial (Medical Device Network)
04:49AM	Loading…
04:49AM	Boston Scientific CFO Dan Brennan to retire after nearly 30 years with the company (MedTech Dive)
Apr-24-25 04:26PM	IBD Stock Of The Day, Boston Scientific, A 'Top Decile' Player, Is Eyeing Two Entries (Investor's Business Daily)
03:41PM	Second phase of ADVANTAGE AF study of FARAPULSE Pulsed Field Ablation System meets primary safety and efficacy endpoints (PR Newswire)
03:25PM	BSX Q1 Earnings Call: Outperformance Driven by Cardiology and Electrophysiology, Guidance Raised Amid Tariff Headwinds (StockStory)
11:39AM	EPD Growth in Emerging Market Supports Abbott Stock Amid Macro Woes (Zacks)
09:45AM	Why Boston Scientific (BSX) is a Top Growth Stock for the Long-Term (Zacks)
03:02AM	Boston Scientific Corp (BSX) Q1 2025 Earnings Call Highlights: Strong Growth and Upgraded ... (GuruFocus.com)
Apr-23-25 11:00PM	Q1 2025 Boston Scientific Corp Earnings Call (Thomson Reuters StreetEvents)
04:07PM	Boston Scientific Jets Higher As Cardio Sales Pump Up First-Quarter Beat (Investor's Business Daily)
01:44PM	Why Boston Scientific (BSX) Stock Is Up Today (StockStory)
11:34AM	Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript (Seeking Alpha)
11:19AM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
11:00AM	Field Medical raises $40M for PFA in ventricular tachycardia (MedTech Dive)
10:28AM	Is Boston Scientific Corp. (NYSE:BSX) the Best Stock Under $100 to Buy According to Hedge Funds? (Insider Monkey)
09:47AM	BSX Q1 Earnings & Revenues Beat, Stock Up, 2025 View Raised (Zacks)
09:35AM	Loading…
09:35AM	Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire (Investopedia)
09:30AM	Boston Scientific (BSX) Reports Q1 Earnings: What Key Metrics Have to Say (Zacks)
08:49AM	Boston Scientific Stock Jets 8% Higher On Solid Quarterly Beat, Hiked Guidance (Investor's Business Daily)
07:59AM	Boston Scientific is very bullish on 2025 despite $200M tariff hit (MedTech Dive)
07:40AM	Boston Scientific (BSX) Q1 Earnings and Revenues Top Estimates (Zacks)
07:12AM	Boston Scientific shares rise on strong Q1 results, raised EPS guidance (Investing.com)
06:45AM	Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan (PR Newswire)
06:39AM	Boston Scientific (NYSE:BSX) Beats Q1 Sales Targets, Next Quarter's Sales Guidance is Optimistic (StockStory)
06:39AM	Boston Scientific: Q1 Earnings Snapshot (Associated Press Finance)
06:30AM	Boston Scientific announces results for first quarter 2025 (PR Newswire)
Apr-22-25 11:07AM	Analyst Report: Boston Scientific Corporation (Morningstar Research)
08:01AM	What To Expect From Boston Scientific's (BSX) Q1 Earnings (StockStory)
07:29AM	Is it Apt to Retain Omnicell Stock in Your Portfolio Now? (Zacks)
Apr-21-25 06:00AM	Intuitive, Boston Scientific and Edwards next up in medtech earnings (MedTech Dive)
Apr-19-25 03:13PM	Is Boston Scientific Corporation (BSX) the Best Low Volatility Stock to Buy Now? (Insider Monkey)
Apr-17-25 06:15PM	Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors (Zacks)
02:00PM	Should You Buy Boston Scientific Stock Ahead of Q1 Earnings? (Zacks)
11:00AM	Reddit initiated, Target downgraded: Wall Streets top analyst calls (TipRanks)
10:48AM	Boston Scientific Corporation (BSX): Among the Innovative Healthcare Stocks to Watch in 2025 (Insider Monkey)
09:15AM	Boston Scientific (BSX) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates (Zacks)
09:12AM	Should You Continue to Hold Veracyte Stock in Your Portfolio? (Zacks)
09:00AM	Reasons to Hold TNDM Stock in Your Portfolio for Now (Zacks)
08:00AM	Medical Products Leader Is An Early Entry Candidate As Shares Bounce From Support (Investor's Business Daily)
Apr-16-25 02:41PM	IYH: Healthcare Dashboard For April (Seeking Alpha)
11:40AM	PAHC or BSX: Which Is the Better Value Stock Right Now? (Zacks)
11:24AM	Needham upgrades Boston Scientific on easing competition, growth opportunities (Investing.com)
10:21AM	Is it the Right Time to Hold STERIS Stock in Your Portfolio? (Zacks)
Apr-15-25 12:22PM	Boston Scientific Corporation (BSX): A Bull Case Theory (Insider Monkey)
Apr-14-25 06:20AM	Should You Invest in the iShares U.S. Medical Devices ETF (IHI)? (Zacks)
Apr-11-25 06:15PM	Boston Scientific (BSX) Ascends But Remains Behind Market: Some Facts to Note (Zacks)
06:45AM	DGX Stock Gains Following the Launch of New AD-Detect Blood Test (Zacks)
Apr-10-25 09:30AM	Boston Scientific (BSX) Is Considered a Good Investment by Brokers: Is That True? (Zacks)
08:31AM	Boston Scientific (BSX) Surges 6.8%: Is This an Indication of Further Gains? (Zacks)
07:16AM	Should You Continue to Hold NVST Stock in Your Portfolio? (Zacks)
Apr-09-25 06:59PM	Analyst Report: Boston Scientific Corporation (Morningstar Research) +6.76%
01:35PM	Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now (Zacks)
09:52AM	Is it the Right Time to Retain Labcorp Stock in Your Portfolio? (Zacks)
08:39AM	Is it the Right Time to Add EYE Stock to Your Portfolio Now? (Zacks)
Apr-08-25 12:04PM	ICUI Stock Gains Following Latest FDA Approvals for Precision IV Pumps (Zacks)
11:57AM	GoodRx Stock Tumbles Despite Launching New Retail Pharmacy Platform (Zacks)
10:02AM	PODD Stock Benefits From the Launch of Omnipod 5 in Canada (Zacks)
09:57AM	Reasons to Retain Penumbra Stock in Your Portfolio for Now (Zacks)
09:46AM	Bruker Announces Groundbreaking 1.3 GHz NMR System, Stock Up (Zacks)
06:46AM	Here's Why You Should Retain CONMED Stock in Your Portfolio for Now (Zacks)
06:46AM	BD Seeks Potential Buyers for Life Sciences Business Division (Zacks)
Apr-07-25 12:15PM	ZBH Stock to Gain From Volume Growth Amid Rising Costs (Zacks)
08:37AM	GMED Stock May Benefit Following the Acquisition of Nevro (Zacks)
07:45AM	Here's Why You Should Hold Accuray Stock in Your Portfolio for Now (Zacks)
Apr-04-25 07:46PM	Analyst Report: Boston Scientific Corporation (Morningstar Research) -8.93%
12:37PM	Reasons to Add Fresenius Medical Stock to Your Portfolio Now (Zacks)
12:36PM	SRDX Stock Dips Despite the Launch of Pounce XL Thrombectomy System (Zacks)
08:09AM	Reasons to Add ABT Stock to Your Portfolio Right Now (Zacks)
08:06AM	RMD Stock Benefits From the Launch of NightOwl Across US (Zacks)
08:06AM	Here's Why You Should Retain DexCom Stock in Your Portfolio for Now (Zacks)
06:51AM	Thermo Fisher Stock Benefits From the Launch of Krios 5 Cryo-TEM (Zacks)
Apr-03-25 06:00PM	Boston Scientific (BSX) Stock Moves -1.55%: What You Should Know (Zacks)
03:00PM	MCK Stock Gains as PRISM Acquisition Adds High-Growth Business (Zacks)
01:25PM	Global Expansion in EPD and Innovations Support Abbott Stock (Zacks)
01:16PM	Here's Why You Should Retain Integer Holdings Stock in Your Portfolio (Zacks)
01:13PM	AngioDynamics Stock Up on Q3 Earnings Beat, Gross Margin Expands (Zacks)
10:38AM	Medical Device Stocks Fall on Tariff Hit (The Wall Street Journal)
09:45AM	Here's Why Boston Scientific (BSX) is a Strong Growth Stock (Zacks)
09:21AM	Bruker Introduces Breakthrough d-DNP Polarizer: Stock to Gain? (Zacks)
09:00AM	Should You Continue to Hold Bio-Rad Stock in Your Portfolio? (Zacks)
07:56AM	ALC Stock May Rise With the Introduction of PanOptix Pro in US (Zacks)
07:54AM	AVNS Stock Gains Following Direct Sales Deal for MIC-KEY in the UK (Zacks)
05:37AM	Boston Scientifics Farapulse matches Medtronic cryoablation in trial (MedTech Dive)
Apr-02-25 03:00PM	MIST Stock Falls 66% Following Complete Response Letter for Cardamyst (Zacks)
02:00PM	3 Stocks to Buy for "Liberation" From Trump Tariffs & Recession Woes (Zacks)
10:10AM	VEEV Stock Slips Despite New Research Site Clinical Trial System (Zacks)

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Brown Vance R	SVP, GC and Corp. Secretary	Apr 21 '25	Sale	95.09	4,826	458,904	36,193	Apr 22 04:09 PM
VANCE BROWN	Officer	Apr 21 '25	Proposed Sale	95.09	4,826	458,904		Apr 21 04:01 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Option Exercise	20.67	105,618	2,183,144	1,758,972	Apr 02 04:12 PM
Mahoney Michael F	Chairman, President & CEO	Apr 01 '25	Sale	100.01	164,442	16,445,072	1,594,530	Apr 02 04:12 PM
MICHAEL F MAHONEY	Officer	Apr 01 '25	Proposed Sale	100.01	164,442	16,445,068		Apr 01 04:11 PM
Brown Vance R	SVP, GC and Corp. Secretary	Mar 21 '25	Sale	100.85	4,826	486,702	41,019	Mar 24 04:26 PM
VANCE BROWN	Officer	Mar 21 '25	Proposed Sale	100.85	4,826	486,702		Mar 21 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Option Exercise	37.50	5,949	223,088	8,063	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 03 '25	Sale	104.97	7,149	750,465	914	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 04 '25	Sale	104.63	482	50,432	432	Mar 05 04:16 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Option Exercise	42.16	7,218	304,311	11,519	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Mar 01 '25	Option Exercise	0.00	837	0	2,469	Mar 03 04:11 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 28 '25	Sale	101.13	9,887	999,872	1,632	Mar 03 04:11 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 24 '25	Sale	104.25	4,675	487,369	28,454	Feb 25 04:41 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 25 '25	Sale	104.00	2,688	279,552	25,766	Feb 25 04:41 PM
JEFFREY B MIRVISS	Officer	Feb 25 '25	Proposed Sale	104.00	2,688	279,552		Feb 25 04:02 PM
Zane Ellen M	Director	Feb 24 '25	Sale	104.23	13,586	1,416,134	34,944	Feb 24 04:08 PM
JEFFREY B MIRVISS	Officer	Feb 24 '25	Proposed Sale	104.25	4,675	487,369		Feb 24 04:01 PM
Zane Ellen M	Director	Feb 24 '25	Proposed Sale	104.23	13,586	1,416,088		Feb 24 11:30 AM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 21 '25	Sale	104.64	4,826	504,993	45,845	Feb 21 04:15 PM
VANCE BROWN	Officer	Feb 21 '25	Proposed Sale	104.64	4,826	504,993		Feb 21 04:03 PM
Sorenson John Bradley	EVP, Global Operations	Feb 19 '25	Sale	105.19	3,303	347,443	20,991	Feb 19 04:23 PM
Sorenson John Bradley	EVP, Global Operations	Feb 18 '25	Sale	104.41	2,657	277,417	24,294	Feb 19 04:23 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 19 '25	Sale	105.35	1,510	159,078	33,129	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Option Exercise	25.61	60,523	1,550,275	293,141	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 19 '25	Sale	105.24	67,333	7,086,111	225,808	Feb 19 04:23 PM
Brennan Daniel J.	EVP and CFO	Feb 18 '25	Sale	104.57	17,530	1,833,184	232,618	Feb 19 04:23 PM
DANIEL BRENNAN	Officer	Feb 19 '25	Proposed Sale	105.24	67,333	7,086,109		Feb 19 04:05 PM
JEFFREY B MIRVISS	Officer	Feb 19 '25	Proposed Sale	105.35	1,510	159,078		Feb 19 04:01 PM
JOHN B SORENSON	Officer	Feb 19 '25	Proposed Sale	105.19	3,303	347,443		Feb 19 04:01 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 14 '25	Option Exercise	0.00	661	0	3,867	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 16 '25	Option Exercise	0.00	636	0	4,188	Feb 18 05:53 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 17 '25	Option Exercise	0.00	667	0	4,584	Feb 18 05:53 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Option Exercise	0.00	2,115	0	27,609	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 16 '25	Option Exercise	0.00	1,273	0	26,716	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 17 '25	Option Exercise	0.00	1,500	0	27,635	Feb 18 05:52 PM
Sorenson John Bradley	EVP, Global Operations	Feb 14 '25	Sale	106.31	1,201	127,678	25,443	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	1,123	0	13,702	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 14 '25	Option Exercise	0.00	106	0	1,650	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	990	0	14,362	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 16 '25	Option Exercise	0.00	85	0	1,697	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	1,000	0	15,071	Feb 18 05:52 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 17 '25	Option Exercise	0.00	100	0	1,767	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 14 '25	Option Exercise	0.00	2,776	0	32,477	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 16 '25	Option Exercise	0.00	2,970	0	34,181	Feb 18 05:52 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 17 '25	Option Exercise	0.00	3,334	0	36,160	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 14 '25	Option Exercise	0.00	16,524	0	1,643,475	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 16 '25	Option Exercise	0.00	16,265	0	1,651,750	Feb 18 05:52 PM
Mahoney Michael F	Chairman, President & CEO	Feb 17 '25	Option Exercise	0.00	18,334	0	1,662,219	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 14 '25	Option Exercise	0.00	4,362	0	179,108	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 16 '25	Option Exercise	0.00	3,960	0	181,078	Feb 18 05:52 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 17 '25	Option Exercise	0.00	4,167	0	183,439	Feb 18 05:52 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 14 '25	Option Exercise	0.00	3,172	0	20,935	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 16 '25	Option Exercise	0.00	2,546	0	21,947	Feb 18 05:50 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 17 '25	Option Exercise	0.00	2,834	0	23,550	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 14 '25	Option Exercise	0.00	1,850	0	50,101	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 16 '25	Option Exercise	0.00	1,839	0	51,045	Feb 18 05:50 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 17 '25	Option Exercise	0.00	1,000	0	51,155	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 14 '25	Option Exercise	0.00	4,362	0	247,700	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 16 '25	Option Exercise	0.00	4,243	0	249,833	Feb 18 05:50 PM
Brennan Daniel J.	EVP and CFO	Feb 17 '25	Option Exercise	0.00	4,584	0	252,365	Feb 18 05:50 PM
JOHN B SORENSON	Officer	Feb 18 '25	Proposed Sale	104.41	2,657	277,417		Feb 18 04:09 PM
DANIEL BRENNAN	Officer	Feb 18 '25	Proposed Sale	104.57	17,530	1,833,184		Feb 18 04:09 PM
Carruthers Wendy	Officer	Feb 14 '25	Proposed Sale	106.45	9,393	999,911		Feb 14 05:32 PM
Woodworth Emily	SVP, Global Controller and CAO	Feb 12 '25	Option Exercise	0.00	480	0	3,437	Feb 14 05:30 PM
Sorenson John Bradley	EVP, Global Operations	Feb 12 '25	Option Exercise	0.00	1,731	0	26,024	Feb 14 05:30 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 12 '25	Option Exercise	0.00	961	0	12,917	Feb 14 05:30 PM
O'Sullivan Miriam	SVP, Chief HR Officer	Feb 12 '25	Option Exercise	0.00	65	0	1,567	Feb 14 05:30 PM
Mahoney Michael F	Chairman, President & CEO	Feb 12 '25	Option Exercise	0.00	13,704	0	1,633,577	Feb 14 05:29 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 12 '25	Option Exercise	0.00	2,115	0	30,569	Feb 14 05:29 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Feb 12 '25	Option Exercise	0.00	3,462	0	176,325	Feb 14 05:29 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 12 '25	Option Exercise	0.00	2,692	0	18,713	Feb 14 05:29 PM
Brown Vance R	SVP, GC and Corp. Secretary	Feb 12 '25	Option Exercise	0.00	1,442	0	48,675	Feb 14 05:28 PM
Brennan Daniel J.	EVP and CFO	Feb 12 '25	Option Exercise	0.00	3,654	0	245,105	Feb 14 05:28 PM
JOHN B SORENSON	Officer	Feb 14 '25	Proposed Sale	106.31	1,201	127,678		Feb 14 04:02 PM
Sorenson John Bradley	EVP, Global Operations	Feb 12 '25	Sale	105.06	6,389	671,249	24,293	Feb 13 04:32 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Feb 12 '25	Sale	105.06	13,022	1,368,073	28,454	Feb 13 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Dec 03 '24	Buy	90.29	50	4,515	148,168	Feb 13 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Dec 10 '24	Sale	89.97	20	1,799	148,148	Feb 13 04:32 PM
Brennan Daniel J.	EVP and CFO	Feb 12 '25	Option Exercise	16.31	15,087	246,069	256,538	Feb 13 04:31 PM
Brennan Daniel J.	EVP and CFO	Feb 12 '25	Sale	105.07	15,087	1,585,135	241,451	Feb 13 04:31 PM
LUDWIG EDWARD J	Director	Feb 11 '25	Sale	105.48	12,000	1,265,815	24,398	Feb 12 07:30 PM
DANIEL BRENNAN	Officer	Feb 12 '25	Proposed Sale	105.07	15,087	1,585,135		Feb 12 04:04 PM
JEFFREY B MIRVISS	Officer	Feb 12 '25	Proposed Sale	105.06	13,022	1,368,073		Feb 12 04:04 PM
JOHN B SORENSON	Officer	Feb 12 '25	Proposed Sale	105.06	6,389	671,249		Feb 12 04:03 PM
LUDWIG EDWARD J	Director	Feb 11 '25	Proposed Sale	105.48	12,000	1,265,816		Feb 11 05:42 PM
Sorenson John Bradley	EVP, Global Operations	Feb 07 '25	Sale	104.97	6,528	685,244	26,449	Feb 10 04:48 PM
JOHN B SORENSON	Officer	Feb 07 '25	Proposed Sale	104.97	6,528	685,244		Feb 07 04:02 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 03 '25	Option Exercise	24.81	17,313	429,493	22,815	Feb 04 07:00 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Feb 03 '25	Sale	101.80	17,313	1,762,507	5,502	Feb 04 07:00 PM
ARTHUR C BUTCHER	Officer	Feb 03 '25	Proposed Sale	101.80	17,313	1,762,506		Feb 03 04:02 PM
Sorenson John Bradley	EVP, Global Operations	Jan 01 '25	Option Exercise	0.00	4,469	0	41,565	Jan 03 04:33 PM
Sorenson John Bradley	EVP, Global Operations	Jan 02 '25	Sale	90.02	4,119	370,792	35,319	Jan 03 04:33 PM
Sorenson John Bradley	EVP, Global Operations	Jan 03 '25	Sale	89.86	2,342	210,449	32,977	Jan 03 04:33 PM
Mahoney Michael F	Chairman, President & CEO	Jan 01 '25	Option Exercise	0.00	57,121	0	1,578,326	Jan 03 04:32 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Jan 01 '25	Option Exercise	0.00	10,430	0	38,884	Jan 03 04:32 PM
Mirviss Jeffrey B.	EVP&Pres, Periph Intervent	Jan 03 '25	Sale	89.86	7,152	642,658	28,454	Jan 03 04:32 PM
Fitzgerald Joseph Michael	EVP & Group Pres, Cardiology	Jan 01 '25	Option Exercise	0.00	13,907	0	162,025	Jan 03 04:32 PM
Butcher Arthur C	EVP& Grp Pres, MedSurg & APAC	Jan 01 '25	Option Exercise	0.00	8,940	0	9,918	Jan 03 04:32 PM
Brown Vance R	SVP, GC and Corp. Secretary	Jan 01 '25	Option Exercise	0.00	6,456	0	40,866	Jan 03 04:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

BSX

Boston Scientific Corp

Upgrade your FINVIZ experience